09022

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

May 28, 2012 Cover

Volume 90, Issue 22

As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies

Cover image:

Credit:

Full Article

Volume 90 | Issue 22

« Prev

As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies

Chemical firms take their beef over rates and service to a transportation board

Concerns grow over nanoparticle characterization and purity

Biological Chemistry

New Way To Modify DNA

Zinc finger nickases may challenge zinc finger nucleases as genomic change agents
Policy

A Murky Case Of Technology Theft

Claims and counterclaims obscure truth in case pitting U.S. resin maker against Chinese rival
Policy

Crowdsourcing Cures

NIH initiative aims to partner academics with pharmaceutical companies to revive failed drug candidates
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime